These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11321123)

  • 1. A personal glimpse of clinical infectious diseases: 1949-1999.
    Liu C
    J Microbiol Immunol Infect; 2001 Mar; 34(1):1-7. PubMed ID: 11321123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of drug-resistance and clinical microbiologists in the 21st century].
    Arakawa Y
    Rinsho Byori; 2000 Jan; Suppl 111():1-8. PubMed ID: 10804786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better control of antibiotic resistance.
    Guillemot D; Courvalin P;
    Clin Infect Dis; 2001 Aug; 33(4):542-7. PubMed ID: 11462192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fighting antibiotic resistance].
    Harthug S; Akselsen PE
    Tidsskr Nor Laegeforen; 2008 Oct; 128(20):2343-6. PubMed ID: 19096492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic challenges in the era of antibiotic resistance.
    Lee C
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines and antibiotic resistance.
    Mishra RP; Oviedo-Orta E; Prachi P; Rappuoli R; Bagnoli F
    Curr Opin Microbiol; 2012 Oct; 15(5):596-602. PubMed ID: 22981392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for the prevention of diseases caused by potential bioweapons.
    Hassani M; Patel MC; Pirofski LA
    Clin Immunol; 2004 Apr; 111(1):1-15. PubMed ID: 15093546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism.
    Greenfield RA; Bronze MS
    Curr Opin Investig Drugs; 2004 Feb; 5(2):135-40. PubMed ID: 15043386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance.
    Colgan R; Powers JH
    Am Fam Physician; 2001 Sep; 64(6):999-1004. PubMed ID: 11578036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of antimicrobial use on emergence and selection of resistance].
    Harbarth S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):130-5. PubMed ID: 17309021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against potential biological warfare agents.
    Cieslak TJ; Christopher GW; Kortepeter MG; Rowe JR; Pavlin JA; Culpepper RC; Eitzen EM
    Clin Infect Dis; 2000 Jun; 30(6):843-50. PubMed ID: 10880299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive vaccines against bioterrorism: evaluation of efficacy and safety.
    Horne AD; Clifford J; Goldenthal KL; Kleppinger C; Lachenbruch PA
    Vaccine; 2004 Nov; 23(1):84-90. PubMed ID: 15519711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal use of antibiotic resistance surveillance systems.
    Critchley IA; Karlowsky JA
    Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infectious diseases--the progress is huge--a lot remains to be done].
    Dan M
    Harefuah; 2009 Nov; 148(11):775-7. PubMed ID: 20027982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic challenges posed by bacterial bioterrorism threats.
    Gilligan PH
    Curr Opin Microbiol; 2002 Oct; 5(5):489-95. PubMed ID: 12354556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chloramphenicol (chlorocide) sensitivity of pathogenic agents isolated from adult patients treated at the department for infectious diseases (from January 1967 to October 1972).
    Münnich D; Molnár K
    Ther Hung; 1975; 23(3):108-10. PubMed ID: 1209522
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
    Lieberman JM
    Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.